CardieX
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
55 Lime Barangaroo St Ste 301, Sydney, N...Phone Number
+61 298748761Website
www.cardiex.comRevenue
$7 MillionStock Symbol
CDXIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About CardieX
Cardiex specializes in the development of digital vascular biomarkers and solutions aimed at addressing large-scale cardiovascular health disorders. Their products, including CONNEQT Pulse and SphygmoCor XCEL, are designed for use in healthcare, drug and device development, academia, and wellness. The company targets a diverse clientele, including healthcare providers, researchers, and patients, by providing tools for arterial health assessment and remote patient monitoring. Cardiex's technology enables informed treatment decisions and accelerates drug development through reliable vascular health data.Explore more
CardieX Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CardieX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on CardieX recently announced quarterly report
Product Launch: Get notified when CardieX launches new products
Click to see if CardieX had a recent Job posting/layoffs
Check out if CardieX is spiking on competitors!
Check if CardieX has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once CardieX has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
CardieX, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at CardieX
Recommended Actions
Find VP level buyers at CardieX
Find 2 more new buyers
Compare Similar Companies to CardieX
Compare insights from companies similar to CardieX, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CardieX is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CardieX is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CardieX.
CardieX financials insights
Gather financial insights about CardieX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Share Placement
$4.3M
CardieX Tech Stack
A closer look at the technologies used by CardieX
Most Recent Scoops
Person-Based
Project
Product Development, Research & Development, Intellectual Property, Legal Affairs
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Funding
CardieX News & Media
Using Real-World Evidence To Enhance Drug Development: Arterial Health Monitoring Innovations, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how central blood pressure and pulse wave analysis offer critical insights for generating real-world evidence (RWE) in drug development. Attendees will learn how accurate arterial health data enhances assessments of drug efficacy and safety in trials and...Cardiex Awarded $525,000 Grand Prize in NIH RADx Tech for Maternal Health Challenge
SYDNEY, Oct. 15, 2024 /PRNewswire/ -- Cardiex, a global health technology company specializing in cardiovascular diagnostics and devices, today announced it has been awarded the $525,000 grand prize in the US National Institutes of Health (NIH) RADx Tech for Maternal Health Challenge. The...Cardiex Announces Publication of Breakthrough Study Validating Noninvasive Fingertip Photoplethysmography (PPG) for Central Aortic Pressure Waveform Analysis
SYDNEY, Sept. 26, 2024 /PRNewswire/ -- Cardiex Limited (ASX: CDX), a global health technology company focused on cardiovascular diagnostics and arterial health solutions, today announced the publication of a peer-reviewed study validating its innovative method for measuring central aortic pressure—an important indicator of heart health—using a noninvasive fingertip sensor. The study, co-authored by Cardiex's team, was published in the respected journal Pulse. The study, titled "Validation of NonCardiex Completes HEARTsense Wearable Study and Secures US Wearable Patent | INN
CARDIEX Limited (ASX:CDX) (CARDIEX, the Company) is pleased to announce the successful completion of two significant milestones in the commercialization of its wearable biomarker technology. Successful Completion of HEARTsense Wearable Study. The Company has successfully completed its primary study ...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding CardieX
Sign Up For FreeTo access detailed company insights
Cardiex specializes in the development of digital vascular biomarkers and solutions aimed at addressing large-scale cardiovascular health disorders. Their products, including CONNEQT Pulse and SphygmoCor XCEL, are designed for use in healthcare, drug and device development, academia, and wellness. The company targets a diverse clientele, including... Read More
